Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016.

Cazabon, Danielle; Pande, Tripti; Kik, Sandra; Van Gemert, Wayne; Sohn, Hojoon; Denkinger, Claudia; Qin, Zhi Zhen; Waning, Brenda; Pai, Madhukar

Cazabon, Danielle; Pande, Tripti; Kik, Sandra; Van Gemert, Wayne; Sohn, Hojoon; Denkinger, Claudia; Qin, Zhi Zhen; Waning, Brenda; Pai, Madhukar.

Afiliación

Cazabon D; McGill International TB Centre, McGill University, Montreal, QC, Canada.
Pande T; McGill International TB Centre, McGill University, Montreal, QC, Canada.
Kik S; Foundation for Innovative New Diagnostics, FIND, Geneva, Switzerland.
Van Gemert W; Stop TB Partnership, Geneva, Switzerland.
Sohn H; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Denkinger C; Foundation for Innovative New Diagnostics, FIND, Geneva, Switzerland.
Qin ZZ; Stop TB Partnership, Geneva, Switzerland.
Waning B; Stop TB Partnership, Geneva, Switzerland.
Pai M; McGill International TB Centre, McGill University, Montreal, QC, Canada.

Gates Open Res ; 2: 35, 2018.

Article en En | MEDLINE | ID: mdl-30234198

Palabras clave

Xpert MTB/RIF; access; diagnostics; market penetration; tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Qualitative_research Idioma: En Revista: Gates Open Res Año: 2018 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google